250 related articles for article (PubMed ID: 29275930)
21. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
[TBL] [Abstract][Full Text] [Related]
22. [Application of molecular analysis in differential diagnosis of ovarian adult granulosa cell tumors].
Zheng XZ; Ma JH; Chen TB; Xu F; Zou ZY; Zhang LH; Jin YL; Zhan Y
Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):794-799. PubMed ID: 32746545
[No Abstract] [Full Text] [Related]
23. Correlation of FOXL2 with Inhibin and Calretinin in the Diagnosis of Ovarian Sex Cord Stromal Tumors.
Rathore R; Arora D; Agarwal S; Sharma S
Turk Patoloji Derg; 2017; 33(2):121-128. PubMed ID: 28272677
[TBL] [Abstract][Full Text] [Related]
24. DICER1 hotspot mutations in non-epithelial gonadal tumours.
Witkowski L; Mattina J; Schönberger S; Murray MJ; Choong CS; Huntsman DG; Reis-Filho JS; McCluggage WG; Nicholson JC; Coleman N; Calaminus G; Schneider DT; Arseneau J; Stewart CJ; Foulkes WD
Br J Cancer; 2013 Nov; 109(10):2744-50. PubMed ID: 24136150
[TBL] [Abstract][Full Text] [Related]
25. Inhibin immunohistochemical staining: a practical approach for the surgical pathologist in the diagnoses of ovarian sex cord-stromal tumors.
Zheng W; Senturk BZ; Parkash V
Adv Anat Pathol; 2003 Jan; 10(1):27-38. PubMed ID: 12502966
[TBL] [Abstract][Full Text] [Related]
26. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
[No Abstract] [Full Text] [Related]
27. Gynecologic Manifestations of the DICER1 Syndrome.
Stewart CJ; Charles A; Foulkes WD
Surg Pathol Clin; 2016 Jun; 9(2):227-41. PubMed ID: 27241106
[TBL] [Abstract][Full Text] [Related]
28. Microcystic Stromal Tumor: A Distinctive Ovarian Sex Cord-Stromal Neoplasm Characterized by FOXL2, SF-1, WT-1, Cyclin D1, and β-catenin Nuclear Expression and CTNNB1 Mutations.
Irving JA; Lee CH; Yip S; Oliva E; McCluggage WG; Young RH
Am J Surg Pathol; 2015 Oct; 39(10):1420-6. PubMed ID: 26200099
[TBL] [Abstract][Full Text] [Related]
29. DICER1 hot-spot mutations in ovarian gynandroblastoma.
Wang Y; Karnezis AN; Magrill J; Tessier-Cloutier B; Lum A; Senz J; Gilks CB; McCluggage WG; Huntsman DG; Kommoss F
Histopathology; 2018 Aug; 73(2):306-313. PubMed ID: 29660837
[TBL] [Abstract][Full Text] [Related]
30. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
[TBL] [Abstract][Full Text] [Related]
31. FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
Wessman S; Fuentes BB; Severin-Karlsson J; Westbom-Fremer S; Nistér M; Kokaraki G; Petta TB; Haglund F; Carlson JW
Int J Gynecol Pathol; 2024 Jan; 43(1):78-89. PubMed ID: 37255476
[TBL] [Abstract][Full Text] [Related]
32. Steroidogenic acute regulatory protein is a useful marker for Leydig cells and sex-cord stromal tumors.
Dong L; Wang H; Su Z; Niu S; Wang R; Wu L; Chen G
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):226-32. PubMed ID: 21217523
[TBL] [Abstract][Full Text] [Related]
33. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
[TBL] [Abstract][Full Text] [Related]
34. Perspectives on testicular sex cord-stromal tumors and those composed of both germ cells and sex cord-stromal derivatives with a comparison to corresponding ovarian neoplasms.
Roth LM; Lyu B; Cheng L
Hum Pathol; 2017 Jul; 65():1-14. PubMed ID: 28445692
[TBL] [Abstract][Full Text] [Related]
35. Cytologic features of sex cord-stromal tumors in women.
Edmund LN; Salama AM; Murali R
Cancer Cytopathol; 2022 Jan; 130(1):55-71. PubMed ID: 34411449
[TBL] [Abstract][Full Text] [Related]
36. Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors.
Baillard P; Genestie C; Croce S; Descotes F; Rouleau E; Treilleux I; Gouy S; Morice P; Ray-Coquard I; McCluggage WG; Devouassoux-Shisheboran M
Am J Surg Pathol; 2021 Feb; 45(2):223-229. PubMed ID: 32910017
[TBL] [Abstract][Full Text] [Related]
37. Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors.
Hes O; Vaněček T; Petersson F; Grossmann P; Hora M; Perez Montiel DM; Steiner P; Dvořák M; Michal M
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):347-51. PubMed ID: 21293260
[TBL] [Abstract][Full Text] [Related]
38. Detection of the DICER1 hotspot mutation alongside immunohistochemical analysis may provide a better diagnostic measure for ovarian Sertoli-Leydig cell tumors.
Zhang X; Shen D; Wang Y
Pathol Res Pract; 2018 Sep; 214(9):1370-1375. PubMed ID: 30072170
[TBL] [Abstract][Full Text] [Related]
39. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours.
Rabban JT; Zaloudek CJ
Histopathology; 2013 Jan; 62(1):71-88. PubMed ID: 23240671
[TBL] [Abstract][Full Text] [Related]
40. Testicular Neoplasms With Sex Cord and Stromal Components Harbor a Recurrent Pattern of Chromosomal Gains.
Acosta AM; Sholl LM; Maclean F; Kao CS; Ulbright TM
Mod Pathol; 2024 Jan; 37(1):100368. PubMed ID: 37871653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]